2020 FLASCO Spring Session with Business of Oncology Summit

The Business of Oncology Summit is developed and managed separate from the FLASCO Spring Session meeting. The Business of Oncology Summit was developed with industry, medical provider, patient, and payer in mind, to provide the opportunity for communication and collaboration. Pharmaceutical representatives, physicians, advance practice providers, nurses, practice administrators, pharmacists, social workers, financial counselors and others that are concerned with the business side of the oncology field are invited to attend. This conference will provide an emphasis on the business of oncology that focuses on specific financial driven topics addressing the current and future challenges in the landscape of cancer care.

The theme for the Business of Oncology Summit is, “Barriers to Access”. Understand the BURDENS to INNOVATIVE CARE. The Spring Session is a clinical focused meeting. Both events will offer continuing education hours. During the Spring Session, attendees will hear a panel discussion on new treatments for prostate cancer and presentation on cancer-related venous thromboembolism and biosimilars.

There are NO exhibits during the Business of Oncology Summit. The first opportunity to exhibit is on Friday, April 3, at 6:00 pm and will run until 7:30 pm and then again on Saturday, April 4 at 7:00 am. Please reference the meeting announcement that holds the agenda and exhibit information. Please contact the FLASCO office to register to exhibit during the Spring Session. 

Please email info@flasco.org for additional information or assistance.